ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1488

Correlation between Lung Ultrasound, HRCT Findings and  Pulmonary Function Tests  in Primary Sjögren’s Syndrome (pSS)-Associated  Interstitial Lung Disease

Francesco Ferro1, Alessandra Bulleri2, Andrea Delle Sedie1, Simone Barsotti1, Nicoletta Luciano1, Elisa Cioffi3, Elena Elefante1, Gianfranco Puppo4, Marta Mosca1 and Chiara Baldini5, 1Rheumatology Unit, University of Pisa, Pisa, Italy, 2Radiology Unit, University of Pisa, Pisa, Italy, 3Rheumatology Unit, Rheumatology Unit, University of Pisa, Pisa, Italy, 4Pneumology Unit, University of Pisa, Pisa, Italy, 5Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Lung Disease, Sjogren's syndrome and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Sjögren's Syndrome Poster II: Clinical Research

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Recently, pleural irregularity (PI), a new lung ultrasound (US) sign, has been proposed as an emerging tool for the diagnosis of interstitial lung disease (ILD) in connective tissue diseases. However, few data are available regarding its role in the evaluation of ILD associated to primary Sjögren’s syndrome (pSS). Aim of this study was to assess the accuracy of PI-US in detecting pSS-associated ILD by correlating PI-US findings with chest high-resolution computed tomography (HRTC) and pulmonary function tests.

Methods: Eighteen patients with pSS-associated ILD were included in the study. HRCT and tests of pulmonary function were performed in each patient. PI-US was performed by a single operator using a MyLab-25 (Esaote), 10 MHz, 5 cm linear probe. PI was defined as the loss of the normal hyperechoic linear pleural contour (score 0-2: normal, minimal and major changes at each intercostal space). PI US total score represented the sum of partial scores assigned to 6 lung fields (2 for the anterior, 2 for postero-superior and 2 for postero-inferior chest surface). Abnormal findings at HRCT were quantified by an expert radiologist according to the Warrick score.

Results: We included in this study 18 patients with pSS-related associated ILD (14 F:4 M, mean age =68.8 ±9.9 yrs). The median PI-US score was 45 (range 25.5-73.5). Both PI-US total score and partial postero-inferior PI-US score strongly correlated with the Warrick HRCT score (r= 0.813, p=0.000 and r= 0.914, p=0.000). Regarding pulmonary function tests, the Warrick HRCT score correlated with FVC (r=-0.753, p=0.001), TLC (r=-0.853, p=0.000), and DLCO (r=-0.834, p=0.000). Similarly, PI-US total score and partial PI-US postero-inferior score correlated inversely with FVC (r=-0.849, p=0.000 and r=-0.836, p=0.000), TLC (r=-0.895, p=0.000 and r=-0.829, p=0.000), and DLCO (r=-0.953, p=0.000 and r=-0.883, p=0.001). Finally, both PI-US score and PI-US of the infero-posterior field (but not Warrick HRCT score) directly correlated with FEV1/SVC (r=0.701, p=0.004 and r=0.619, p=0.01) and with FEV1/FVC (r=0.600, p=0.02 and r=0.501, p=0.05).

Conclusion: This study demonstrated a high correlation between PI-US, HRCT findings and pulmonary function tests, supporting the use of lung ultrasonography in clinical practice for the assessment of pSS-associated ILD. The exclusive correlation between PI-US scores and both FEV1/SVC and FEV1/FVC seemed to indicate a higher sensitivity of PI-US with respect to HRCT in ILD assessment. Further studies are warranted to clarify the role of PI-US for the early diagnosis of ILD.


Disclosure: F. Ferro, None; A. Bulleri, None; A. Delle Sedie, None; S. Barsotti, None; N. Luciano, None; E. Cioffi, None; E. Elefante, None; G. Puppo, None; M. Mosca, None; C. Baldini, None.

To cite this abstract in AMA style:

Ferro F, Bulleri A, Delle Sedie A, Barsotti S, Luciano N, Cioffi E, Elefante E, Puppo G, Mosca M, Baldini C. Correlation between Lung Ultrasound, HRCT Findings and  Pulmonary Function Tests  in Primary Sjögren’s Syndrome (pSS)-Associated  Interstitial Lung Disease [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/correlation-between-lung-ultrasound-hrct-findings-and-pulmonary-function-tests-in-primary-sjogrens-syndrome-pss-associated-interstitial-lung-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-between-lung-ultrasound-hrct-findings-and-pulmonary-function-tests-in-primary-sjogrens-syndrome-pss-associated-interstitial-lung-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology